Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Gulati

Showing results (141-150 of 147) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 147 results.
Neurosurgery|November 15, 2013
High response rates and prolonged survival in patients with corticotroph pituitary tumors and refractory Cushing disease from capecitabine and temozolomide (CAPTEM): a case seriesBrad E Zacharia, Anthony P Gulati, Jeffrey N Bruce, et al.
Molecular Carcinogenesis|November 4, 2005
Mutant human tumor suppressor p53 modulates the activation of mitogen-activated protein kinase and nuclear factor-kappaB, but not c-Jun N-terminal kinase and activated protein-1Anthony P Gulati, Yang-Ming Yang, David Harter, et al.
Journal of Perinatology : Official Journal of the California Perinatal Association|May 16, 2009
Early amino-acid administration improves preterm infant weightC J Valentine, S Fernandez, L K Rogers, et al.
Cancer Chemotherapy and Pharmacology|February 2, 2013
Capecitabine and temozolomide (CAPTEM) for metastatic, well-differentiated neuroendocrine cancers: The Pancreas Center at Columbia University experienceRobert L Fine, Anthony P Gulati, Benjamin A Krantz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 25, 2020
Local delivery of CAR T cells targeting fibroblast activation protein is safe in patients with pleural mesothelioma: first report of FAPME, a phase I clinical trialS Hiltbrunner, C Britschgi, P Schuberth, et al.
JAMA Oncology|June 17, 2021
Association of Convalescent Plasma Therapy With Survival in Patients With Hematologic Cancers and COVID-19Michael A Thompson, Jeffrey P Henderson, Pankil K Shah, et al.
Lancet (London, England)|June 1, 2020
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort studyNicole M Kuderer, Toni K Choueiri, Dimpy P Shah, et al.
Pageof 15

Showing results (141-150 of 147) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 147 results.
Neurosurgery|November 15, 2013
High response rates and prolonged survival in patients with corticotroph pituitary tumors and refractory Cushing disease from capecitabine and temozolomide (CAPTEM): a case seriesBrad E Zacharia, Anthony P Gulati, Jeffrey N Bruce, et al.
Molecular Carcinogenesis|November 4, 2005
Mutant human tumor suppressor p53 modulates the activation of mitogen-activated protein kinase and nuclear factor-kappaB, but not c-Jun N-terminal kinase and activated protein-1Anthony P Gulati, Yang-Ming Yang, David Harter, et al.
Journal of Perinatology : Official Journal of the California Perinatal Association|May 16, 2009
Early amino-acid administration improves preterm infant weightC J Valentine, S Fernandez, L K Rogers, et al.
Cancer Chemotherapy and Pharmacology|February 2, 2013
Capecitabine and temozolomide (CAPTEM) for metastatic, well-differentiated neuroendocrine cancers: The Pancreas Center at Columbia University experienceRobert L Fine, Anthony P Gulati, Benjamin A Krantz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 25, 2020
Local delivery of CAR T cells targeting fibroblast activation protein is safe in patients with pleural mesothelioma: first report of FAPME, a phase I clinical trialS Hiltbrunner, C Britschgi, P Schuberth, et al.
JAMA Oncology|June 17, 2021
Association of Convalescent Plasma Therapy With Survival in Patients With Hematologic Cancers and COVID-19Michael A Thompson, Jeffrey P Henderson, Pankil K Shah, et al.
Lancet (London, England)|June 1, 2020
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort studyNicole M Kuderer, Toni K Choueiri, Dimpy P Shah, et al.
Pageof 15